Media headlines about Inovalon (NASDAQ:INOV) have been trending somewhat negative recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Inovalon earned a coverage optimism score of -0.03 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 46.0643360398298 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Inovalon (NASDAQ INOV) opened at $10.45 on Monday. The company has a market capitalization of $1,509.00, a P/E ratio of 43.54, a PEG ratio of 2.99 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a current ratio of 4.82 and a quick ratio of 4.82. Inovalon has a 12-month low of $10.32 and a 12-month high of $17.80.
Inovalon (NASDAQ:INOV) last issued its earnings results on Tuesday, February 20th. The technology company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.01). The firm had revenue of $114.60 million during the quarter, compared to analyst estimates of $116.83 million. Inovalon had a return on equity of 4.79% and a net margin of 7.51%. Inovalon’s revenue was up 19.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.05 EPS. research analysts expect that Inovalon will post 0.25 earnings per share for the current year.
In other news, insider Shauna L. Vernal sold 44,270 shares of Inovalon stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $14.00, for a total value of $619,780.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 48.28% of the stock is currently owned by company insiders.
Inovalon Company Profile
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.